Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
128 Leser
Artikel bewerten:
(0)

Small-Cap Institute, Inc. Partners with ESGAUGE to Analyze Director Compensation in Small-Cap Life Sciences Companies

CARMEL, CA / ACCESSWIRE / February 11, 2020 / Small-Cap Institute, Inc. (SCI), a first-of-its-kind online education community exclusively for officers and directors of publicly-traded companies, today announced the publication of novel research undertaken with data analytics firm ESGAUGE regarding board member compensation in small-cap life sciences companies.

"Nearly 80 percent of public companies in the United States have market capitalizations below $500 million," said David Scher, SCI's founder. "Despite the sheer number of small-cap companies, once you descend below that $500 million market capitalization line, board compensation data is virtually nonexistent for the vast majority of companies. This is especially true for life sciences companies, many of which are pre-revenue. Given the enormous number of these companies, and our mission of providing insightful and unbiased information, we decided to partner with ESGAUGE to deliver this elusive data to SCI members free of charge."

"There were two goals of the SCI-ESGAUGE research," commented Paul Hodgson, senior advisor to ESGAUGE. "First, to increase the availability of data on director compensation in a sector of the economy where such data collection is largely overlooked. Second, to test the hypothesis that director pay in small-cap life sciences companies is generally above the median of similarly sized, non-life sciences companies. Regarding the latter, the data show that in some market cap segments, board members of life sciences companies were paid nearly 130 percent more than their non-life sciences peers."

For maximum utility, board compensation data is set forth in four tranches by market capitalization: (1) below $50 million; (2) between $51-$100 million; (3) between $101-$250 million; and (4) between $251-$500 million.

The complete report is available to Small-Cap Institute, Inc. members on the company's website. For officers and directors of public companies, you can sign up for a complimentary SCI membership here.

About Small-Cap Institute, Inc.

Small-Cap Institute, Inc. is the first and only community exclusively for small-cap executives and board members. The platform is made up of a knowledge library focused on providing objective answers to the problems small-cap leaders face daily, as well as an interactive discussion forum where members can ask questions and share insights with one another. For more information, visit www.smallcapinstitute.com.

For more information, please contact David Scher at david@smallcapinstitute.com

About ESGAUGE

ESGAUGE is a data analytics and data mining firm providing advanced level information with a high degree of granularity to companies seeking customized data on U.S. public companies. It focuses on disclosures regarding environmental, social and governance (ESG) practices, including executive and director compensation, proxy voting analytics, board practices, and sustainability disclosures. Its clients include corporations, compensation consultants, law firms, accounting and audit firms, and investment companies. It also partners on research and analysis projects with think tanks, academic institutions and the media. For more information, visit www.esgauge.com.

SOURCE: Small-Cap Institute, Inc.



View source version on accesswire.com:
https://www.accesswire.com/576010/Small-Cap-Institute-Inc-Partners-with-ESGAUGE-to-Analyze-Director-Compensation-in-Small-Cap-Life-Sciences-Companies

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.